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Abstract
In addition to its role as neurotransmitter, serotonin (5-HT) is an important modulator of inflammation and immunity. Here,
we report novel findings suggesting a 5-HT involvement in T cell migration. In particular, we show that 5-HT tunes the
responsiveness of human T lymphocytes to the broadly expressed chemokine CXCL12 in transwell migration assays. By real-
time PCR, western blot analysis and electrophysiological patch clamp experiments, we demonstrate that the type 3 5-HT
receptor (5-HT3) is functionally expressed in human primary T cells. In addition, specific 5-HT3 receptor agonists selectively
decrease T cell migration towards gradients of CXCL12 but not of inflammatory chemokines, such as CCL2 and CCL5. In
transmigration experiments, 5-HT3 receptor stimulation reverts the inhibitory effect of endothelial-bound CXCL12 on T cell
migration. Our data suggest that the reduced T cell responsiveness to CXCL12 induced by 5-HT may occur to facilitate T cell
extravasation and migration into inflamed tissues.
Citation: Magrini E, Szabo` I, Doni A, Cibella J, Viola A (2011) Serotonin-Mediated Tuning of Human Helper T Cell Responsiveness to the Chemokine CXCL12. PLoS
ONE 6(8): e22482. doi:10.1371/journal.pone.0022482
Editor: Paul Proost, Rega Institute, University of Leuven, Belgium
Received March 22, 2011; Accepted June 22, 2011; Published August 10, 2011
Copyright:  2011 Magrini et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The research leading to these results has received funding from the Italian Association for Cancer Research (AIRC) to I.S. (IG grant nu 5118) and to A.V.
(IG grant nu5629 and RG 6278), the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement nu201106 and EMBO YIP to
A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: elena.magrini@ifom-ieo-campus.it
¤ Current address: Department of Experimental Oncology, European Institute of Oncology, IFOM-IEO Campus, Milan, Italy
Introduction
The monoamine serotonin (5-HT) is known to mediate a
plethora of actions throughout the body. In the central and
autonomous nervous system, 5-HT is utilized by neurons to signal
both volumic and fast synaptic neurotransmission. In the
periphery, 5-HT can both contract and relax smooth muscle
(vascular and gastrointestinal), contract cardiac muscle, regulate
hepatic microcirculation and contribute to blood clotting [1].
Synthesis of 5-HT in the peripheral and central nervous system
is respectively operated by two different isoforms of tryptophan
hydroxylase (TPH), TPH-1 and -2 [2]. These enzymes catalyze
hydroxylation of tryptophan to 5-hydroxytryptophan, the imme-
diate precursor of 5-HT. Though conventionally considered a
neurotransmitter, 5-HT is primarily produced by the enterochro-
maffin cells in the gut [3] and it is taken up via an active transport
mechanism into platelets, which provide a rich reservoir of 5-HT
in the circulation. Subsequent release of platelet-stored 5-HT can
be rapidly triggered by platelet-activating factor, thrombin,
complement fragments C3a and C5a, or immunoglobulin E-
containing immune complexes. Thus, at sites of inflammation and
platelet activation, local concentrations of 5-HT can greatly
exceed the relatively low amounts found free in the serum [4].
Indeed, 5-HT is a known immunoregulator and it is implicated in
several inflammatory diseases [1,5–7]. In the context of the
adaptive immune response, 5-HT affects both T cell and dendritic
cell functions [6,8]. Interestingly, it has been recently reported that
dendritic cells uptake 5-HT at sites of inflammation and shuttle it
to naive T cells, thereby modulating T-cell activation [9],
proliferation and differentiation [10].
The 5-HT receptors have been divided into seven major classes
(5-HT1–5-HT7). The 5-HT3 receptor is the most phylogenetically
conserved; it is described as a ligand-gated ion channel, permeable
to monovalent and divalent cations [11], belonging to the Cys-
loop receptor super-family and sharing structural and functional
features with other members of this channel/receptor group [12].
The 5-HT3 receptor is constituted of five subunits organized in a
channel. To date, five different 5-HT3 receptor subunits were
identified (5-HT3A–E) and, among them, the 5-HT3A subunit is
essential to form a functional receptor, whereas the 5-HT3B
subunit is known to alter the pharmacological properties of the
channel [13,14].
In this study, we analyzed the possible role of 5-HT in T cell
migration. We found that 5-HT selectively inhibits migration
towards CXCL12 through the engagement of 5-HT3 receptor. We
propose that this process likely facilitates T cell infiltration in
inflamed tissues.
Results
5-HT3 receptor activity modulates CXCL12-induced T cell
migration
First, we investigated on the possible modulation of human and
mouse CD4+ primary T cells chemotaxis by 5-HT. The cells were
treated with 5-HT and allowed to migrate in a transwell assay
towards a gradient of CXCL12, a chemokine that binds and
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triggers the chemokine receptor CXCR4. After stimulation with 5-
HT, human CD4+ T cells displayed decreased migration, whereas
the migration of mouse CD4+ T cells was not affected (Figure 1A).
The inhibition of CXCL12-induced human T cell migration
exerted by 5-HT was dose-related in the range from 0.003 to
3 mM (Figure 1B).
The 5-HT3 receptor subtype is expressed in human but not
mouse T cells [9,15] and thus we hypothesized that different
effects of 5-HT on human and mouse T cell migration might
depend on its specific expression. We evaluated T cell migration
after incubation with specific 5-HT3 receptor agonists, SR57227A
and 2-methyl-5-hydroxytryptamine (2M-5HT). As shown in
Figures 2A and 2B, 5-HT3 agonists reduced, in a dose-dependent
manner, CXCL12-induced migration of human resting T cells.
We observed that 5-HT3 receptor agonists and 5-HT had a similar
inhibitory effect on T cell chemotaxis, suggesting that the effects of
5-HT on CXCL12-induced cell migration were most likely
mediated by 5-HT3 receptor engagement. Accordingly, the two
selective 5-HT3 receptor antagonists enhanced T cell chemotactic
response to CXCL12 in the range from 1 to 100 mM (Figure 2C–
D). Similar results were obtained when human T cells activated by
anti-CD3 and anti-CD28 antibodies (Abs) were used (Figure 2E).
The use of different chemicals, including 5-HT, did not alter
neither spontaneous chemotaxis nor modified T cell chemokinesis
(not shown). In addition, in line with the absence of the receptor,
5-HT3 receptor agonist and antagonist did not affect the migration
of mouse T cells (Figure 2F).
Human T cells express functional 5-HT3 receptor and
produce 5-HT
These results prompted us to verify and characterize the
expression of functional 5-HT3 receptors in human CD4
+ T cells.
We employed real-time PCR analysis to evaluate the expression of
5-HT3A and 5-HT3B subunits in primary, resting T lymphocytes
as well as in T cells activated by anti-CD3 and anti-CD28 Abs, or
phytohaemagglutinin (PHA). Activation of CD4+ T cell was
assessed by the up-regulation of activation surface markers, such as
CD69 and CD25 (not shown). As shown in Figure 3A, both resting
and activated human T cells expressed the 5-HT3A receptor
subunit. Moreover, the levels of 5-HT3A transcript increased upon
cell activation (Figure 3A). In contrast, no expression of the 5-
HT3B subunit was found (not shown). Similar results were
obtained by Western blot analysis, which showed that the 5-
HT3A subunit was constitutively expressed by CD4
+ T cells and
that its expression was augmented upon cell activation (Figure 3B).
Next, we assessed the functional properties of the 5-HT3A
receptor in human CD4+ T lymphocytes through electrophysio-
logical patch clamp experiments performed in freshly-isolated T
cells in the whole-cell configuration (Figure 3C–G). In naive T
cells, Kv1.3, a voltage-gated, depolarization-activated potassium
channel, is responsible for maintenance of the resting membrane
potential (around 250 mV) [16]. In accordance, in primary T
lymphocytes we recorded Kv1.3-mediated potassium outward
currents, displaying typical Kv1.3 inactivation kinetics, at
depolarizing voltages (Figure 3C, left panel) but no current was
observed at hyperpolarizing voltages. Upon addition of 5-HT to
the bath, an inward current appeared at negative voltages,
indicating that 5-HT alters ionic currents in T cells (Figure 3C,
right panel). In the experiments shown in Figure 3C, both pipette
and bath solutions contained gluconate, which did not permeate
chloride channels. Therefore, the outward current was due to the
exit of potassium via Kv1.3, while the 5-HT-elicited inward
current was due to the entrance of cations into the cell. Although
5-HT3A homomers also allow calcium permeation, in our
experimental setting the concentration of calcium in the
extracellular solution was too low (1 mM) to give rise to a
significant current [16], suggesting that the major charge carrying
ion was sodium. In line with this, replacing sodium with N-methyl-
D-glucamine ions, which did not permeate through sodium
channels and 5-HT3 receptors, resulted in no agonist-induced
inward current (not shown). Next, to eliminate signals due to
Kv1.3 activity, in the following experiments we applied hyperpo-
larizing potentials (#250 mV) (Figure 3D–G) and cesium - a well-
known blocker of potassium channels - was the only cation present
in the pipette solution. Under these ionic conditions, the addition
of 2M-5HT to resting T cells, which did not display any current at
negative potentials under control condition (Figure 3D, left panel),
elicited activation of negative, inward currents (Figure 3D, right
panel). Moreover, in another representative experiment, addition
of 2M-5HT to cells at 290 mV holding potential in the whole-cell
Figure 1. 5-HT reduces human CD4+ T cell migration towards CXCL12 in a dose-dependent manner. Human primary (n = 3, Panel A;
n = 3, Panel B) or murine naive (n = 3, Panel A) CD4+ T cells were treated with the indicated concentrations of 5-HT for 30 min at RT and then allowed
to migrate towards CXCL12. Number of migrated human CD4+ T cells resulted 12326354 compared to 6856179 for untreated and 5-HT-treated cells,
respectively (mean 6 SEM; Panel A). Percentages of migrated cells for each condition were calculated as described in ‘‘Materials and Methods’’. Data
were statistically analyzed with either t-test (A) or Bonferroni’s multiple comparison test (B); *P,0.05, ***P,0.001.
doi:10.1371/journal.pone.0022482.g001
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configuration caused a significant inward current within few
seconds (Figure 3E). T cells are known to express amiloride-
sensitive sodium channels [17]. To exclude the possibility that the
current recorded after addition of 2M-5HT was due to sodium
influx through amiloride-sensitive channels rather than 5HT3
receptors, currents were recorded either in the absence (Figure 3F,
upper trace) or in the presence of amiloride (Figure 3F, lower
trace). Amiloride did not reduce 2M-5HT-induced currents,
indicating that, upon addition of the 5-HT3 receptor agonist,
sodium did not enter the cells via classical amiloride-sensitive
Figure 2. 5-HT3 receptor activation reduces CXCL12-induced migration of resting and activated CD4
+ T cells. Human resting (A–D),
human activated (E) or murine naive (F) CD4+ T cells were treated with the indicated concentration of 5-HT3 receptor agonists, 2M-5HT (A) and
SR57227A (B), or antagonists, ondansetron (C) and granisetron (D), for 30 min at RT and then used for migration assays towards CXCL12 (n = 3, from
Panel A to Panel D); number of human activated CD4+ T cells migrated in control condition resulted 610261033 compared to 45596846 and
820661407 for 2M-5HT and ondansetron treated cells, respectively (mean 6 SEM, n= 4, Panel E); (n = 3, Panel F). Percentages of migrated cells for
each condition were calculated as described in ‘‘Materials and Methods’’; *P,0.05, **P,0.01, ***P,0.001, Bonferroni’s multiple comparison test.
doi:10.1371/journal.pone.0022482.g002
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Figure 3. Resting and activated human CD4+ T cells express functional 5-HT3 receptor. Human CD4
+ T cells were stimulated with anti-CD3
and anti-CD28 Abs, PHA or PMA plus ionomycin for 72 h. (A) Gene expression for 5-HT3A receptor subunits was examined by real-time PCR. The graph
represents the quantitative analysis of the experiments. Values are expressed as fold increase over resting T cells. Data are mean of triplicates6 SD of
the 22DDCt (n = 3); *P,0.05, **P,0.01, t-test. (B) T cell membranes were isolated by ultracentrifugation from total cell lysates and 20 mg/sample were
separated on SDS-PAGE gel. A representative immunoblot of three experiments performed showing the expression of 5-HT3A subunit is reported.
Asterisk indicates the band corresponding to 5-HT3A monomer. (C–G) Freshly isolated CD4
+ T cells were subjected to electrophysiological patch
clamp experiments in the whole-cell configuration. Cells were held at resting potential (250 mV) and voltage pulses of 400 ms duration were applied
in 20 mV steps ranging from 2130 to 210 mV. Currents were recorded before (C, left panel) and after (C, right panel) addition of 3 mM 5-HT to the
bath solution. Addition of 5-HT induced an inward current at hyperpolarizing voltages. Activity of Kv1.3 resulting in outward potassium current was
seen at depolarizing voltages 230 and 210 mV. Pipette: Kgluconate containing solutions; bath: Nagluconate containing solutions. In the same
experimental conditions, with the exception that cesium was used in the pipette solution and NaCl in the bath solution (D–G), currents were also
recorded before (D, left panel) and after (D, right panel) addition of 3 mM of specific 5-HT3 agonist 2M-5HT to the bath solution. Cesium blocked
outward potassium currents and Kv1.3 activity was avoided by applying voltage pulses only from 2130 to250 mV in 20 mV steps. Addition of 3 mM
2M-5HT to a cell held at 290 mV holding potential in the whole-cell configuration caused a significant inward current within few seconds (E).
Currents were recorded at 270 mV holding potential in outside-out patch after addition of 3 mM 2M-5HT (F, upper trace) and after addition of
Serotonin and T Cell Migration
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sodium channels. In accordance with this observation, 2M-5HT
failed to induce inward currents in cells pre-treated with
ondansetron (Figure 3G).
Human T cells were found to express TPH-1 [18], thus we
asked whether T cells were able to synthesize 5-HT. To this end,
we performed an Ultra-Sensitive Serotonin enzyme immunoassay
(EIA) of supernatants obtained from resting and activated T cell
cultured in medium supplemented with fetal calf serum (FCS) that
was previously treated with charcoal-coated dextran, in order to
absorb the endogenous 5-HT. Consistently with published data
[9], complete media supplemented with 10% FCS contained
276631 nM 5-HT, and this concentration was reduced to
1.160.3 nM following treatment with charcol-coated dextran
(mean 6 SEM, n= 3). Despite the intra-donor variability, in all
experiments performed we measured nanomolar concentrations of
5-HT released by both resting and activated cells (Figure 4A).
However, the 5-HT release was reduced upon T cell activation
(P,0.01). These observations were confirmed by intracellular
staining and flow cytometric analysis (Figure 4B).
5-HT3 receptor stimulation enhances T cell
transmigration through CXCL12-coated endothelial cells
We asked whether 5-HT modulates chemotactic responses
towards chemokines other than CXCL12. Thus, we evaluated the
effects of 5-HT3 receptor agonist (Figure 5A) and antagonist
(Figure 5B) on human T cell migration towards CCL2 or CCL5
gradients. Both 2M-5HT and ondansetron had no effect on T cell
migration towards the inflammatory chemokines CCL2 or CCL5,
indicating that the 5-HT/5-HT3 system did not alter T cell
chemotactic responses to all chemokines and did not act on
general mechanisms required for migration.
In order to investigate the mechanism of 5-HT effect on
CXCL12/CXCR4 response, we evaluated CXCR4 expression,
CXCL12 binding and CXCL12-induced actin polymerization in
T cells after stimulation or inhibition of 5-HT3 receptors. As
shown in Figure 6, neither 5-HT nor 5-HT3 receptor agonists or
antagonists had any detectable effect on CXCR4 expression (Panel
A), CXCL12 binding to its receptor (Panel B) or CXCR4-
mediated early signaling (Panel C).
CXCL12 is present on the surface of endothelial cells [19] and
thus we evaluated if 5-HT might influence T cell extravasation, by
regulating endothelial-bound CXCL12-chemoattraction. To ad-
dress this question, we compared the ability of human T
lymphocytes, treated or not with the specific CXCR4 antagonist
AMD3100 [20], to migrate towards an inflammatory stimulus,
such as CCL2, through CXCL12-coated endothelial cells.
Endothelial-bound CXCL12 had an inhibitory effect on T cell
transendothelial migration and, interestingly, 5-HT3 receptor
stimulation by 2M-5HT enhanced transendothelial migration of
T cells, whereas 5-HT3 receptor inhibition through ondansetron
strongly reduced it (Figure 7). All these effects were specifically
determined by the presence of endothelial-bound CXCL12, as
they were abrogated by AMD3100 (Figure 7). Moreover, they did
not depend on the presence of CCL2, which was simply used as a
chemoattractive stimulus, given that 2M-5HT or ondansetron
exhibited no effect on migration towards this chemokine, as
previously demonstrated (Figure 5).
Discussion
The attraction of leukocytes to the sites of inflammation and
infection is an essential component of the host response to diseases.
The recruitment of circulating leukocytes from the blood stream
into inflamed tissues is driven by chemokines, produced either by
infiltrating inflammatory cells or by injured tissue cells. This
process depends on three distinct phases: vascular attachment of
Figure 4. 5-HT is produced and released by human CD4+ T cells. (A) Cell-released 5-HT was quantified by EIA. Data are mean of triplicate 6
SEM (n= 3). (B) Representative flowcytometric analysis of three experiments performed showing intracellular 5-HT in primary and activated human T
cells (MFI, normalized to isotype control staining, was 70.563.5 and 361 for resting and activated T cells, respectively; n = 3, P,0.01).
doi:10.1371/journal.pone.0022482.g004
100 mM amiloride, in the presence of 2M-5HT, to the same patch (F, lower trace). Amiloride did not reduce the current. Whole-cell currents were
recorded in presence of ondansetron (100 mM) (G, left panel) and after addition of 3 mM 2M-5HT in the presence of 100 mM ondansetron (G, right
panel). Applied voltages ranged from 2130 to 210 mV. Data in Figures 3C–G are representative of at least five experiments in the same conditions
giving similar results.
doi:10.1371/journal.pone.0022482.g003
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leukocytes to the luminal side of blood vessels, extravasation
(transendothelial migration) and cell migration.
Platelets, at the sites of inflammation, play a crucial role as
amplifiers of leukocyte adhesion to the endothelium because of
their repertoire of adhesion molecules and soluble mediators [21].
5-HT, one of the soluble mediators locally released by platelets, is
emerging as a key regulator of immunity, tuning in a very complex
way both innate and acquired responses [3,6,22]. In agreement, 5-
HT seems to be directly involved in the pathogenesis of several
inflammatory diseases, including irritable bowel syndrome [23],
colitis [24], contact allergy [25], atopic dermatitis [26], psoriasis
[27] and asthma [28]. Moreover, recent studies have demonstrat-
ed that platelet-derived 5-HT aggravates T-cell induced liver
damage in viral hepatitis [29,30].
The data reported in this study indicate that 5-HT inhibits
migration of human T cells towards CXCL12 gradients and that
this effect depends on the activity of 5-HT3 receptors, which are
functionally expressed in human T cells.
The presence of functional 5-HT3 receptor has been already
described in the Jurkat T cell line using the fluorescent probe
SBFI/AM [31]. Here, through the patch clamp technique, we
show the presence of 5-HT3 receptor agonist-induced inward
currents, which are abolished by pre-incubation with 5-HT3
receptor antagonist, in human peripheral blood T cells, demon-
strating for the first time that 5-HT3 receptors are also active in
human primary T cells.
Interestingly, our data indicate that T cells produce 5-HT and
suggest that they use it as an autocrine factor to reduce
responsiveness to CXCL12. Indeed, all our chemotaxis experi-
ments have been performed in serum-free conditions and hence in
the absence of external or contaminant sources of 5-HT. In these
conditions, the boosting effect of 5-HT3 receptor antagonists on T
cell migration suggests - but does not formally prove - that self-
produced 5-HT controls responsiveness to CXCL12. In addition,
T cells are able to sense an increase in the concentration of
extracellular 5-HT, and respond with a further reduction of
responsiveness to CXCL12 stimulation.
One puzzling aspect of our findings concerns the molecular
basis for the selective action of the serotonin receptor 5-HT3 on
CXCL12/CXCR4. A trivial explanation for the selective control
of CXCL12-induced migration may be a direct modulation of the
expression of CXCR4 - the CXCL12 receptor - by 5-HT.
However, CXCR4 expression and its affinity for the chemokine
are not altered by 5-HT or by 5-HT3 receptor agonists or
antagonists. Moreover, 5-HT3 receptor stimulation or inhibition
do not alter actin polymerization in response to CXCL12,
indicating that the early events following CXCR4 stimulation
are not affected by 5-HT. The mechanism responsible for the
specific modulation of CXCL12-induced T cell migration by the
5-HT system is therefore still unclear and may involve pHi
regulation. Chemotaxis is indeed modulated by the contribution of
several different ion channels and by pHi changes [32–35],
although the precise mechanisms are still not clear.
CXCL12 regulates both homeostatic and pro-inflammatory
migration and homing of lymphocytes [36–38] and we suggest that
the selective control of T cell responses to CXCL12 by 5-HT may
be important in these contexts. Notably, it has been previously
observed that the neutrophil elastase cleaves CXCL12 expressed on
the bone marrow stroma, thus facilitating stem cell mobilization
from bone marrow into the peripheral circulation [39,40]. In
addition, another study has shown that elastase release by
transmigrating neutrophils deactivates endothelial-bound CXCL12
and attenuates subsequent T lymphocyte transendothelial migra-
tion [41]. Our data indicate that an additional mechanism has
evolved to selectively control responsiveness of lymphocytes to
CXCL12. We suggest that, reducing responsiveness to endothelial-
bound CXCL12 chemoattraction, 5-HT facilitates transendothelial
T cell migration towards gradients of inflammatory chemokines
released in inflamed tissues. Data obtained with 5-HT3 receptor
antagonists do not exclude the possibility that T cells themselves
may control their responsiveness to CXCL12 in an autonomous
manner. On the other hand, since released local concentrations of
5-HT consequent to platelet activation at sites of damaged
endothelium greatly exceeds the relatively low amounts produced
by T cells, our straightforward interpretation is that during T cell
transendothelial migration the major source of 5-HT is most likely
produced by platelets. In addition, the fact that activated T cells
produce lower amounts of 5-HT than resting ones but up-regulate
expression of 5-HT3 receptor may indicate that, upon activation, T
cells become more dependent on external sources of 5-HT released,
for example, by platelets.
In conclusion, our data unveil a novel connection between 5-
HT and chemokines that may play a crucial role during tissue
damage and inflammatory responses.
Figure 5. 5-HT3 receptor activity selectively modulates CXCL12-induced chemotaxis of human CD4
+ T cells. Human resting CD4+ T cells
were treated with 2.5 mM 2M-5HT (n = 3, Panel A) or 100 mM ondansetron (n = 3, Panel B) for 30 min at RT, and then allowed to migrate towards
CXCL12, CCL2 or CCL5. Percentages of migrated cells for each condition were calculated as described in ‘‘Materials and Methods’’. **P,0.01,
***P,0.001, t-test.
doi:10.1371/journal.pone.0022482.g005
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Materials and Methods
Ethics statement
Human peripheral blood T (PBT) cells were isolated from Buffy
coats, a by-product of the isolation of blood coagulation factors,
obtained from healthy donors at the Centre for Blood Transfu-
sions of the Desio or Padua Hospital. The Centres for Blood
Transfusions collected blood donations after a written informed
consent, and did not release to our laboratory any personal data of
the blood donors. For all these reasons, our Institution did not
require approval from the local ethics committee.
Procedures involving animals and their care conformed with
institutional guidelines (authorisation n. 11/2006-A from the
Italian Ministry of Health) in compliance with national (4D.L.
N.116, G.U., suppl. 40, 18-2-1992) and international law and
policies (EEC Council Directive 86/609, OJ L 358,1,12-12-1987;
NIH Guide for the Care and Use of Laboratory Animals, US
National Research Council 1996). All efforts were made to
minimize the number of animals used and their suffering. Full
details of the study were approved by Istituto Clinico Humanitas
Animal Care and Use Committee (IACUC).
Cell culture and activation
Human CD4+ PBT cells were isolated from the peripheral
blood of healthy donors by negative selection using RosetteSep kit
(StemCell Technologies) and cultured in RPMI 1640 medium
(Lonza) supplemented with non essential amino acids,1 mM
sodium pyruvate, 2 mM L-glutamine, 10 mM Hepes buffer
(Lonza) (complete) and 10% FCS (Euroclone). In some experi-
ments, human cells were activated by culture for 72 hours (h) in
the presence of 2.5 mg/ml plate-bound functional grade purified
anti-human CD3 Ab (OKT3; eBioscience) and 1 mg/ml of
purified NA/LE anti-human CD28 Ab (CD28.2; BD Biosciences)
in solution, with 2.5 mg/ml of PHA (Biochrom AG) or with a
combination of 10 nM of phorbol 12-myristate 13-acetate (PMA;
Sigma) and 1 mM of ionomycin (Sigma). T cell activation was
determined by labeling with anti-human CD25 Ab (2A3; BD
Figure 6. 5-HT3 receptor activity does not modify CXCR4 expression, CXCL12 binding and CXCL12-induced actin polymerization.
(A) After treatment of resting human CD4+ T cells with 5-HT, the 5-HT3 receptor agonist 2M-5HT or the 5-HT3 receptor antagonist ondansetron for 0,
30 and 150 min, CXCR4 expression was analyzed by flow cytometry. Data refer to percentage of a representative experiment of three performed. (B)
Binding of CXCL12-AF647 on human CD4+ T cells. The cells were treated for 30 min at RT with 5-HT, 2M-5HT, ondansetron or the specific CXCR4
antagonist AMD3100 (ref. 20). The cells were then incubated with increasing concentrations of fluorescent CXCL12, in the presence of the indicated
chemicals. Data are expressed as MFI 6 SEM vs. CXCL12-AF647 concentrations (n = 4; ***P,0.001, Bonferroni’s multiple comparison test). (C) Human
CD4+ T cells were treated with 2M-5HT or ondansetron for 30 min at RT and then stimulated with CXCL12. Kinetics of CXCL12-induced F-actin
formation were analyzed by phalloidin staining and flow cytometric analysis. Data represent MFI 6 SEM vs. time (n = 3).
doi:10.1371/journal.pone.0022482.g006
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Biosciences) and anti-human CD69 Ab (FN50; BD Biosciences).
The expression of CXCR4 was assessed by labeling with anti-
human CD184 (CXCR4) Ab (12G5; BD Biosciences). Samples
were analyzed using a FACS Canto flow cytometer and FACS
Diva software (BD Biosciences).
Murine naive CD4+ T cells were obtained from the lymph
nodes of C57BL/6 mice. Cells were sorted by negative selection
using a mixture of rat anti-mouse CD8 (TIB105), CD19 (1D3),
CD11b (A506) Abs and anti-rat IgG microbeads according to the
manufacturer’s instructions (Miltenyi Biotec). Murine CD4+ T
cells were cultured in complete DMEM medium (Lonza)
supplemented with 50 mM b-mercaptoethanol (Gibco) and 10%
FCS. Percentage of CD4+ cells was determined by flow cytometric
analysis after labeling with anti-mouse CD4 Ab (GK1.5;
BioLegend).
Human umbilical vein endothelial cells (HUVECs) were gently
gifted by M. Sironi (Milan, Italy) [42]. HUVECs were cultured in
Medium 199 (Lonza) supplemented with 2 mM L-glutamine,
100 U/ml penicillin/streptomycin (Lonza), 100 mg/ml heparin
(Sigma), 50 mg/ml EC growth supplement (ECGS; Biomedical
Technologies, Inc.) and 20% FBS in flasks coated with 1% gelatine
(Sigma) in PBS16 (Lonza) for at least 2 h at 37uC.
Chemicals
5-HT, 2M-5HT, SR57227A, ondansetron hydrochloride dehy-
drate, granisetron hydrochloride, amiloride hydrochloride hydrate
and AMD3100 were all purchased from Sigma. Stock solutions
and intermediate dilutions of 5-HT and 5-HT3 agonists or
antagonists were freshly prepared in water before each experiment
and kept on ice protected from direct light.
Real-time PCR
Total RNA from human CD4+ T cells was extracted using
RNAspin Mini RNA isolation Kit (GE Healthcare) and treated
with TURBO DNA-free Kit (Ambion). Total RNA from human
dorsal root ganglion (hDRG; Clontech) was used as positive
control. Reverse transcription was performed using the Super-
script III First-Strand Synthesis System (Invitrogen). Real-time
PCR was performed using SYBR Green PCR Master Mix
(Applied Biosystems) and detected by 7900HT Sequence Detec-
tion System (Applied Biosystems). The following primers were
used: human 18S (forward: 59-CGCCGCTAGAGGTGAA-
ATTC-39 and reverse: 59-CTTTCGCTCTGGTCCGTCTT-
39), human 5-HT3A (forward: 59-GCTTGCCAGAAAAGGTG-
AAATC-39 and reverse: 59-GGCGGATGACCACATAGAACT-
T-39), human 5-HT3B (forward: 59-CCCTACCTCTAAGTGC-
CATCT-39 and reverse: 59-GGCTTATAGTTCTCAATGGT-
CCC-39).
Data were analyzed using the SDS2.2.2 software (Applied
Biosystems). The fold increase corresponded to 22DDCt, where the
DCt was the difference of the mean value of the Ct between the
studied and the housekeeping gene (18S ribosomal RNA), and the
DDCt was the difference of the DCt between activated and resting
cells for each gene. The standard deviation (SD) of the 22DDCt was
calculated applying the formula: SD of DDCt * 2
2DDCt * ln2.
Western blotting
Human CD4+ T cells were collected on ice-cold 50 mM Tris-
HCl (pH=7.5), 2 mM EDTA containing protease inhibitors
(Complete EDTA-free protease inhibitor cocktail tablets; Roche)
(hypotonic buffer). Nuclei were eliminated by centrifugation
(300 g, 10 min, 4uC) and membranes were isolated by further
centrifugation (48.000 rpm, rotor Type 90 Ti, 45 min, 4uC) and
solubilized in hypotonic buffer containing 1% NP40 (Calbiochem).
Total protein concentration was determined by DC Protein assay
(Bio-Rad Laboratories). Specifically, 20 mg of total protein for each
sample were diluted in XT sample buffer (Bio-Rad Laboratories)
containing 10% b-mercaptoethanol (Bio-Rad Laboratories), boiled
for 10 min and stored at 220uC until use. Western blots were
immunolabeled using polyclonal rabbit anti-human 5HT3 recep-
tor Ab (1 mg/ml; Imgenex) and secondary HRP–conjugated goat
anti–rabbit IgG Ab (GE Healthcare). Membrane chemilumines-
cence was acquired using a ChemiDoc XRS system and the
Quantity One – 4.6.1 software (Bio-Rad Laboratories).
Patch clamp
Freshly isolated human CD4+ T lymphocytes were subjected to
electrophysiological patch clamp experiments in the whole-cell
configuration (or outside out patch in Figure 3F). Whole-cell
currents were recorded with an EPC-7 amplifier (List) as
previously described [43] and data were analyzed by using
pCLAMP8 program set (Axon Instruments). Leak currents were
not subtracted. The bath solution was composed of 156 mM
Nagluconate, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES
(pH=7.3) and the intracellular solution contained 134 mM
Kgluconate, 1 mM CaCl2, 1 mM MgCl2, 10 mM EGTA,
10 mM HEPES (pH=7.3) for experiments where Kv1.3 activity
and 5HT3 activities were recorded. In some control experiments,
to block inward cation current, in the bath solution Nagluconate
was replaced with N-methyl-D-glucamine chloride (NMDGCl).
Where indicated, intracellular Kgluconate was replaced with
134 mM CsCl (pH to 7.3 with CsOH) to block outward potassium
current and the bath contained NaCl instead of Nagluconate.
5-HT detection
To quantify 5-HT, CD4+ T cells (56106 cells/ml) were
incubated for 24 or 72 h at 37uC in complete RPMI 1640
medium supplemented with 10% charcoal/dextran-treated FBS,
Figure 7. 5-HT3 receptor activation enhances T cell transmi-
gration through CXCL12-coated endothelial cells. Human resting
CD4+ T cells were treated with 2.5 mM 2M-5HT or 100 mM ondansetron
for 30 min at RT. Then, CD4+ T cells were incubated (+) or not (2) with
the CXCR4 antagonist AMD3100 (10 mM) and immediately used for a
transendothelial migration assay towards CCL2 through CXCL12-coated
endothelial cells. In absence of AMD3100, number of migrated control
cells resulted 15246270 compared to 18886252 and 12346398 for 5-
HT and ondansetron treated cells, respectively (mean 6 SEM).
Percentages of migrated cells for each condition were calculated as
described in ‘‘Materials and Methods’’. n = 5, *P,0.05, Bonferroni’s
multiple comparison test.
doi:10.1371/journal.pone.0022482.g007
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0,1% (w/v) L-ascorbic acid (Labor Diagnostika Nord), 30 mM
tranylcypromine (Sigma). FCS was pretreated with 0.25% (w/v)
charcoal-coated dextran (Sigma) overnight at 4uC. 5-HT released
into T cell culture supernatants was quantified using the Ultra-
Sensitive Serotonin enzyme immunoassay (EIA; Labor Diagnos-
tika Nord); same pretreated media was used as assay diluent. For
intracellular staining cells were fixed with paraformaldehyde 4%
for 15 min at 4uC and stained with monoclonal mouse anti-
serotonin (5HT-H209; Dako) and AlexaFluor488-goat anti-mouse
IgG (Molecular Probes) using the BD Cytofix/Cytoperm kit (BD
Biosciences) according to the manufacturer’s instructions. Mean of
Fluorescence Intensity (MFI) was measured by FACS Canto flow
cytometer and analyzed by Flow-Jo software.
CXCL12 binding assay
T cells were washed once with Hanks’ balanced salt solution
containing 20 mM Hepes and 0.2% BSA (Sigma) at pH=7.4 and
resuspended in the same buffer. First, they were treated for 30 min
at RT with the indicated chemicals and then incubated for 30 min
at RT with different concentrations of CXCL12-AF647 (Almac
Sciences) in the range from 0 to 1000 ng/ml. Thereafter, cells
were washed twice in assay buffer and fixed in 1% paraformal-
dehyde in PBS. MFI was measured by FACS Canto flow
cytometer and analyzed with FACS Diva software.
Actin polymerization assay
After 5 hours of serum starvation in RPMI 1640 medium, T
cells were treated for 30 min at RT with the indicated chemicals
and then stimulated with CXCL12 (100 nM) at 37uC in a rotary
shaker. At indicated time points, stimulation was stopped by
adding 4% formaldehyde. Intracellular staining for F-actin was
performed by AlexaFluor488–phalloidin (Molecular Probes) using
the BD Cytofix/Cytoperm kit (BD Biosciences) according to the
manufacturer’s instructions. MFI was measured by FACS Canto
flow cytometer and analyzed with FACS Diva software.
Migration assays
Cell migration in response to chemokine was tested using
Transwell assays (24-well plate with inserts, 3 mm pore/6.5 mm,
TC-treated; Costar). Briefly, after 2 h of serum starvation in
migration medium (serum-free RPMI 1640 supplemented with
0.1% BSA), 5-HT, 5-HT3 receptor agonists or antagonists were
added for 30 min at RT to cell suspension and then cell were used
for migration assays. 5-HT3 receptor agonists and antagonists
were present during the migration in both transwell compart-
ments. Human (1.5 nM) and murine (6.3 nM) CXCL12 were
purchased from PeproTech; human CCL2 (11.5 nM) and CCL5
(12.8 nM) were purchased from R&D; chemokines were all diluted
in migration medium. The number of living cells spontaneously
migrating through the filter was determined after 2 h at 37uC by
counting all the samples for the same time (1 min) at FACS Canto
flow cytometer.
HUVECs were seeded at 15–206103/well and cultured to 90%
confluence on 24-well transwell tissue culture inserts (24-well plate
with inserts, 5 mm pore/6.5 mm, TC-treated; Costar) as previ-
ously described [42]. HUVECs were activated using IL-1b
(Peprotech) at 10 ng/ml final concentration for 4 h at 37uC in
HUVEC-culture medium and then incubated with CXCL12
20 ng/ml final concentration in migration medium for 15 min at
37uC. T cells were treated for 30 min at RT with the indicated
chemicals, then incubated with AMD3100 10 uM and immedi-
ately allowed to migrate towards CCL2 (11.5 nM) for 30 min at
37uC. AMD3100, 5-HT3 receptor agonists and antagonists were
present during the migration in both transwell compartments.
Migration experiments displayed an inter-donor variability in the
absolute number of migrating T cells, thus for each experiment
migration data have been normalized considering the number of
counted cells in control conditions as 100%.
Statistical analysis
All experiments were performed at least three times. All results are
expressed as mean 6 the standard error of the mean (SEM). The
statistical significance was calculated using a Student’s t-test or a one-
way ANOVA, Bonferroni’s multiple comparison test (GraphPad
Prism 4). Differences were considered significant if P,0.05.
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